In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents
- PMID: 3566246
- PMCID: PMC174684
- DOI: 10.1128/AAC.31.2.164
In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents
Erratum in
- Antimicrob Agents Chemother 1990 Aug;34(8):1622
Abstract
The antimicrobial susceptibility of Borrelia burgdorferi isolated from human spinal fluid was determined in vitro and in vivo. A broth dilution technique was used to determine the MBCs of four antimicrobial agents. The Lyme disease spirochete was most susceptible to ceftriaxone (MBC, 0.04 microgram/ml) and erythromycin (MBC, 0.05 microgram/ml), then tetracycline (MBC, 0.8 microgram/ml), and finally penicillin G (MBC, 6.4 micrograms/ml). Syrian hamsters were used to determine the 50% curative doses (CD50s) of the four antimicrobial agents. Ceftriaxone and tetracycline had the highest activities, with CD50s of 24.0 and 28.7 mg/kg [corrected], respectively. Both erythromycin and penicillin G possessed low activities. The CD50 of erythromycin was 235.3 mg/kg [corrected], and the CD50 of penicillin G was greater than 197.5 mg/kg [corrected].
Similar articles
-
Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents.Antimicrob Agents Chemother. 1990 Nov;34(11):2133-6. doi: 10.1128/AAC.34.11.2133. Antimicrob Agents Chemother. 1990. PMID: 2073103 Free PMC article.
-
In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin.J Antimicrob Chemother. 1990 Jan;25 Suppl A:33-8. doi: 10.1093/jac/25.suppl_a.33. J Antimicrob Chemother. 1990. PMID: 2154436
-
In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics.Infection. 1996 Jan-Feb;24(1):60-3. doi: 10.1007/BF01780660. Infection. 1996. PMID: 8852472
-
Management of Lyme disease.Clin Pharm. 1990 Mar;9(3):192-205. Clin Pharm. 1990. PMID: 2180624 Review.
-
Isolation techniques for spirochetes and their sensitivity to antibiotics in vitro and in vivo.Rev Infect Dis. 1989 Sep-Oct;11 Suppl 6:S1505-10. doi: 10.1093/clinids/11.supplement_6.s1505. Rev Infect Dis. 1989. PMID: 2682963 Review.
Cited by
-
Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children--a prospective study.Infection. 1991 Jul-Aug;19(4):279-83. doi: 10.1007/BF01644967. Infection. 1991. PMID: 1917046 Clinical Trial.
-
Therapy of Lyme borreliosis in children.Infection. 1996 Mar-Apr;24(2):170-3. doi: 10.1007/BF01713333. Infection. 1996. PMID: 8740116
-
beta-lactam antibiotics in the treatment of neuroborreliosis in children: preliminary results.Infection. 1996 Mar-Apr;24(2):174-7. doi: 10.1007/BF01713334. Infection. 1996. PMID: 8740117
-
In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites.Antimicrob Agents Chemother. 1996 Nov;40(11):2632-6. doi: 10.1128/AAC.40.11.2632. Antimicrob Agents Chemother. 1996. PMID: 8913478 Free PMC article.
-
Dialysis culture enables more accurate determination of MIC of benzylpenicillin for Borrelia burgdorferi than does conventional procedure.Antimicrob Agents Chemother. 1996 Dec;40(12):2882-3. doi: 10.1128/AAC.40.12.2882. Antimicrob Agents Chemother. 1996. PMID: 9124859 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources